The Latest
-
Informa TechTarget
Note from the Editor-in-Chief
A change in ownership and what it means for our readers.
-
Sittipol Sukuna via Getty Images
Sponsored by IFSThe power of composability: Overcoming field service management challenges in MedTech
Composable software seamlessly integrates with core systems, facilitating communication and real-time data sharing between diverse systems.
-
aprott via Getty Images
Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs
About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.
-
Spencer Platt/Getty Images via Getty Images
Medtronic wins VA contract to install AI-powered endoscopy units
The three-year contract expands Medtronic’s work with the VA to cover the installation of almost 100 more GI Genius endoscopy modules at U.S. centers.
-
Permission granted by Embecta
Embecta discontinues insulin patch pump development
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.”
-
gorodenkoff via Getty Images
Zimmer wins FDA approval for cementless partial knee implant
The device is established in Europe, where the company said it has a 60% market share, but will be the first product of its type available in the U.S.
-
Chip Somodevilla via Getty Images
Trump calls for 25% tariffs on imports from Canada and Mexico
The president-elect also called for additional 10% tariffs on imports from China as part of his day one White House plans.
Updated Nov. 26, 2024 -
Courtesy of Intera Oncology
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.
-
Noam Galai via Getty Images
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA
A prolific medical researcher and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.
-
Courtesy of Medtronic
Medtronic, Tempus testing AI to find potential TAVR patients
The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not have a treatment plan in place.
-
Courtesy of Medtronic
Medtronic buys surgical instrument developer Fortimedix
Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.
-
Sarah Silbiger via Getty Images
FDA plan would alert public sooner on high-risk device recalls
The Center for Devices and Radiological Health’s pilot program is meant to cut the time between the FDA’s awareness of potentially high-risk recalls and when the public is notified.
-
Courtesy of Medtronic
Medtronic nets FDA nod for smart insulin pen app
The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous glucose monitor for people who take multiple daily insulin injections.
-
Rebecca Noble via Getty Images
Healthcare industry braces for RFK Jr.
Kennedy's views on vaccines in particular are causing alarm among some physicians and investors.
-
Bruce Bennett via Getty Images
Henry Schein to acquire medical supplier Acentus
Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.
-
Courtesy of Identifeye Health
Verily alum looks to improve access to retinal scans
CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google’s sibling Verily and Grail.
-
Patrik Stollarz / Staff via Getty Images
Philips revises ventilator directions after airflow issue tied to 4 injuries
Aerosol deposits could accumulate on a sensor and affect oxygen delivery, the FDA said in a recall notice. Several of the ventilator models were previously recalled for separate problems.
-
Win McNamee / Staff via Getty Images
Advamed CEO welcomes Dr. Oz as Trump’s pick to lead CMS
Scott Whitaker said Mehmet Oz knows firsthand the impact of medical technologies on disease prevention and treatment. Oz holds a patent on Abbott’s Mitraclip heart device.
-
Courtesy of Ōura
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
The partnership will support data flows that enable people who use both companies’ devices to track how glucose levels affect other health metrics.
-
Permission granted by Labcorp
Labcorp hires Julia Wang as CFO
Wang will replace Glenn Eisenberg, who is retiring after 10 years in the role. Evercore analysts called Eisenberg a Labcorp “institution.”
-
Win McNamee/Getty Images via Getty Images
Trump nominates Dr. Oz to oversee Medicare, Medicaid as CMS head
On Truth Social, President-elect Donald Trump said Oz, who is best known for his eponymous TV show, would take on the “illness industrial complex.”
-
Courtesy of Medtronic
Medtronic’s ablation sales slowed by PFA supply issues
CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues that have now been resolved.
-
Permission granted by Abbott
Abbott opens plant in Ireland to boost Libre 3 sensor production
More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.
-
Courtesy of Johnson & Johnson
The PFA race is heating up. Here’s where the market stands after J&J’s approval.
Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space as new devices and heart imaging technology hit the market.
-
Courtesy of Boston Scientific
Boston Scientific’s Watchman could be new option for patients post ablation: study
The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent cardiac ablation for AFib.
-
Courtesy of Getinge
FDA warns providers on Getinge devices tied to 17 serious injuries
Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices to its shortages list following the recall.
